Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD
PHASE1Not yet recruitingINTERVENTIONAL
Enrollment
18
Participants
Timeline
Start Date
April 1, 2025
Primary Completion Date
October 30, 2026
Study Completion Date
December 31, 2026
Conditions
CTD-ILD
Interventions
BIOLOGICAL
MSC
a single injection dose i.v.
Trial Locations (1)
Unknown
Shanghai Sixth People's Hospital, Shanghai
All Listed Sponsors
lead
Shanghai IxCell Biotechnology Co., LTD
OTHER
NCT06823063 - Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD | Biotech Hunter | Biotech Hunter